Ursodeoxycholic Acid (UDCA) – Patient Information (UK)

Ursodeoxycholic acid (often called UDCA) is a bile acid medicine used in specific liver and gallbladder conditions. It works by helping bile flow more effectively and by changing the composition of bile to reduce the effects of toxic bile components.

This page explains what ursodeoxycholic acid is, how it works, how it is taken, what to expect, and key safety information for people in the United Kingdom.

Basic product information

Ursodeoxycholic acid is a naturally occurring bile acid produced in small amounts in the human body. Medicines containing UDCA are designed to increase the proportion of “protective” bile acids and to help reduce bile-related inflammation and injury.

In the UK, brands and strengths can vary (commonly tablets or capsules). Always check your pack for the exact strength and the instructions provided with your product.

How ursodeoxycholic acid works (mechanism of action)

Bile is produced by the liver and helps your body digest fats. Bile acids can also irritate or damage liver and bile duct tissues when their balance is abnormal or when bile flow is impaired.

UDCA helps in several ways:

• Improves bile composition: It replaces more hydrophobic (less favourable) bile acids with UDCA, making bile less irritating to cells.
• Supports bile flow: UDCA may increase the secretion of bile and promote more normal flow through the biliary system.
• Protects liver cells: It can reduce bile-acid–related toxicity, supporting healthier liver cell function.
• For certain gallstones: It may help gradually dissolve cholesterol-rich gallstones by reducing cholesterol saturation in bile.

Pharmacokinetics (how the body handles UDCA)

Pharmacokinetics describes what happens to the medicine after you take it—absorption, distribution, metabolism, and elimination. UDCA is absorbed from the intestine and undergoes metabolism in the liver.

• Absorption: UDCA is absorbed from the small intestine.
• Distribution: It is carried in blood bound to proteins and then taken up by the liver and bile system.
• Metabolism: The liver and intestinal bacteria process bile acids. UDCA is partially converted into metabolites.
• Elimination: UDCA and its metabolites are eliminated mainly through bile into the gut, with some excreted in faeces.

Overall, UDCA behaves as a bile acid that circulates through enterohepatic pathways (a natural cycle between liver and intestine). This is one reason timing with meals can matter for some people.

Typical uses (indications) in the UK

UDCA is used for specific conditions where bile acid imbalance and bile-related injury play an important role. Use depends on clinical assessment, investigations, and suitability for the individual.

Commonly used indications

• Primary biliary cholangitis (PBC): UDCA is often used to improve liver biochemistry and slow disease progression.
• Cholestatic liver disorders: In some cholestatic conditions, UDCA may help improve bile flow and reduce cholestasis effects.
• Some cholesterol gallstones: UDCA may be considered for selected gallstones (for example, radiolucent cholesterol stones) when surgery is not appropriate. Effect can be slow and stones may recur.

Your clinician will confirm the diagnosis and whether UDCA is an appropriate option based on imaging, bile duct status, liver tests, and overall risk.

Who should avoid UDCA or seek specialist advice?

UDCA may not be suitable for everyone. Seek medical guidance if you have any of the following (your prescriber will advise):

• Complete bile duct obstruction (blockage preventing bile flow).
• Acute gallbladder inflammation or biliary colic with complications.
• Known hypersensitivity to ursodeoxycholic acid or any ingredients in your product.
• Severe liver disease progression where specialist management is needed (monitoring is essential in these cases).

How to take ursodeoxycholic acid (timing and dosing)

Follow the directions on your medicine label and any advice from your healthcare professional. Doses can differ depending on the condition, your weight, and your liver and bile test results.

Timing with meals

• Food effects: UDCA can be influenced by food, because bile release and digestion change after eating. Some people are advised to take UDCA with meals or divided doses across the day.
• Consistency matters: Try to take UDCA at the same times each day to support steady levels.

Typical adult dosing (general guidance)

Dosing is condition-specific. A common approach in PBC involves daily dosing based on body weight. For gallstones, dosing and duration vary and may take many months.

Important: Do not rely on general figures alone. Use your individual prescription instructions (including number of tablets/capsules per dose). If you are unsure, check the pack or speak to a pharmacist.

Duration

• PBC and chronic cholestatic conditions: Treatment is often long-term and benefits are judged by regular blood tests.
• Gallstone dissolution: Improvement can be slow; it may take a long time to show meaningful changes on imaging. Many people need follow-up scans to assess response.
• Stopping early: Do not stop abruptly unless advised by your clinician—stopping can reverse benefits.

Food interactions (what to watch)

Because UDCA is a bile acid, your digestive process can affect how it performs. Food may change bile production and fat digestion, influencing how UDCA is taken up.

Practical food-related tips

• Take as directed: If your clinician advises “with food,” follow this closely.
• Fatty meals: Large, very fatty meals may increase bile secretion and may affect GI comfort for some people.
• Consistency: Keep your meal schedule fairly regular, especially if your dose is split.

Fibre and supplements

Fibre supplements are generally safe, but if you are also taking other medications, spacing may be helpful. If you use bile acid binders (see next section), the timing becomes particularly important.

Alcohol and medicine interactions

Alcohol

Alcohol can affect the liver and may worsen certain liver conditions. If you are taking UDCA for a liver or bile-related condition, it is generally sensible to keep alcohol to a minimum or avoid it, and to discuss a safe level with your clinician.

Other medicine interactions

Several medicines can interact with bile acids or affect bile composition. Tell your pharmacist or clinician about all medicines you take, including over-the-counter products and herbal supplements.

Key interaction classes

• Bile acid sequestrants (bile acid binders): Examples include medicines like cholestyramine. These bind bile acids in the intestine and can reduce absorption/effect of UDCA. Spacing is usually required if both are used—ask your pharmacist for a schedule.
• Cholesterol-lowering medicines and certain lipid treatments: Some products influence bile composition. Discuss your full medication list with your clinician.
• Medicines affecting liver enzymes or bile transport: Because UDCA is processed in the liver and gut, some medicines may change its levels. Your pharmacist can check interaction risks.

What to do if you miss a dose

• Take it when you remember if it is not close to the next dose.
• Do not take double to make up for a missed dose.
• If you often miss doses, consider setting reminders or speaking to a pharmacist about simplifying your schedule.

Safety profile (side effects and warnings)

Like all medicines, ursodeoxycholic acid can cause side effects. Not everyone experiences them, and some symptoms may overlap with underlying conditions. Report new or worsening symptoms promptly.

Common side effects

• Diarrhoea (or loose stools)
• Abdominal discomfort
• Nausea

Less common or serious issues (seek advice urgently)

Contact urgent care or your healthcare team promptly if you experience symptoms that could indicate a serious reaction or complication, such as:

• Severe allergic reaction (swelling of face/lips, difficulty breathing, severe rash)
• Marked worsening of jaundice or severe abdominal pain
• Persistent vomiting or signs of dehydration

When extra monitoring is important

• If you have ongoing liver disease, your clinician will usually monitor liver blood tests periodically.
• If you are being treated for gallstones, follow-up imaging may be needed to confirm response and rule out complications.
• For children or adolescents (if applicable), dosing and monitoring should be specialist-led.

Pregnancy, breastfeeding, and fertility

If you are pregnant, planning pregnancy, or breastfeeding, discuss UDCA with your clinician. Benefits and risks depend on the condition being treated. Your prescriber will guide safe use based on your situation.

Practical use tips (to get the best results)

• Keep a consistent routine: Take your dose at the same times each day.
• Use meal timing your label recommends: If your instructions say “with food,” take it with meals.
• Track symptoms: For example, note changes in itching, fatigue, stool consistency, or abdominal discomfort.
• Attend follow-up blood tests: UDCA benefits are often assessed using liver function tests and other markers.
• Don’t stop early: UDCA may require long-term use for chronic conditions.
• Check interactions: If you start a new medicine, ask a pharmacist whether UDCA spacing is needed.

Alternative options

Treatment depends on the underlying diagnosis. Alternatives may include lifestyle measures, other medicines, and in some cases procedural or surgical options. Below are common alternatives considered in practice—your clinician will decide what is appropriate for you.

For cholestatic liver conditions

• Other bile-flow–supporting therapies: Depending on cause and severity.
• Symptom-targeted treatment: For example, treatments to manage itching or nutritional deficiencies.
• Specialist monitoring and advanced therapies: In more advanced disease, specialist care may be required.

For selected cholesterol gallstones

• Surgical management: Often discussed when symptoms or risks warrant it.
• Other medical approaches: Not all gallstones respond to medication, and eligibility depends on stone type and bile duct status.
• Watchful waiting: Sometimes considered for low-risk cases.

If you are considering stopping UDCA or switching alternatives, speak to a healthcare professional first—especially for long-term liver conditions.

Market and legal context in the United Kingdom

Medicines containing ursodeoxycholic acid are regulated in the UK under the Medicines and Healthcare products Regulatory Agency (MHRA). Availability may depend on the specific product formulation and whether it is classified as a prescription-only medicine or supplied via pharmacy routes in certain circumstances.

In the UK, medicines are subject to quality, safety, and manufacturing standards, including requirements for packaging, labelling, and adverse event reporting. Always use medicine exactly as directed on the label and the information leaflet supplied with your pack.

Recent guidance and clinical practice (overview)

In recent years, clinical practice and guidelines for cholestatic liver diseases—particularly primary biliary cholangitis (PBC)—have focused on:

• Early treatment with UDCA for appropriate patients.
• Ongoing monitoring using liver blood tests to assess response.
• Escalation of therapy when response is inadequate, typically under specialist hepatology/gastroenterology care.

Local healthcare services may use specific assessment methods and treatment targets. Your clinician will explain how response is measured and what to do if treatment goals are not met.

Delivery and availability (UK)

UDCA products may be available through online pharmacies and/or in-store pharmacies depending on the product’s classification and stock availability. Availability can vary between different brands and strengths.

• Dispatch times: Delivery schedules depend on the pharmacy provider and local delivery partner.
• Packaging: Medicines are typically dispatched in protective packaging to help prevent damage in transit.
• Cold chain: UDCA products are generally stored at room temperature; check your pack instructions.
• Order accuracy: Ensure you select the correct strength and form (tablet/capsule) as instructed.

If you need help choosing the correct product strength or formulation, contact the pharmacy’s customer support or speak to a pharmacist.

Storage

• Store in the original packaging.
• Keep out of sight and reach of children.
• Store at room temperature unless your pack specifies otherwise.
• Check the leaflet for expiry date and specific storage instructions.

FAQ

1) What is ursodeoxycholic acid used for?

Ursodeoxycholic acid is used for certain bile-related conditions, including primary biliary cholangitis (PBC) and other selected cholestatic liver disorders. It may also be used for selected cholesterol gallstones in people who meet specific criteria.

2) How long does UDCA take to work?

Many benefits are assessed over months. With chronic liver conditions, your clinician will review liver blood tests periodically. With gallstones, changes can be slow and follow-up imaging may be required.

3) Should I take UDCA with food?

Follow the instructions on your label or from your healthcare professional. Food can influence bile release and digestion. If you’ve been advised to take it with meals, try to keep the same routine daily.

4) Can I drink alcohol while taking UDCA?

Alcohol may affect the liver. If you are taking UDCA for a liver or bile-related condition, it is generally best to avoid or limit alcohol and discuss a safe approach with your clinician.

5) What should I do if I get diarrhoea?

Mild diarrhoea can occur. Stay hydrated and contact a pharmacist if it persists, becomes severe, or is accompanied by severe abdominal pain, fever, or dehydration. Your healthcare team may adjust your treatment depending on the cause.

6) Are there any medicines I should not take with UDCA?

Some medicines can interfere with bile acid absorption, including bile acid binders (such as cholestyramine). If you take other medicines—especially for cholesterol—ask a pharmacist about spacing and interaction risk.

7) What if I miss a dose?

Take the missed dose when you remember unless it’s close to the next scheduled dose. Do not take a double dose to make up for a missed one.

8) Can UDCA cure primary biliary cholangitis?

UDCA can help improve liver tests and slow progression in many people, but it may not “cure” PBC. Long-term management and monitoring are often needed. If response is inadequate, specialists may consider additional treatments.

9) Is UDCA safe for everyone?

UDCA is not suitable for all people and may be avoided in certain conditions (for example, complete bile duct obstruction). If you have existing bile duct problems, severe liver impairment, or allergies to bile-acid–related medicines, discuss suitability with your clinician.

10) Where can I get advice if I have questions?

If you have symptoms, side effects, or concerns about interactions, contact a pharmacist. For worsening jaundice, severe abdominal pain, or signs of an allergic reaction, seek urgent medical care.

Summary

Ursodeoxycholic acid (UDCA) is a bile acid medicine used for selected bile-related liver conditions and certain cholesterol gallstones. It works by improving bile composition and supporting healthier bile flow. Benefits may take time, and safety depends on correct use, monitoring, and awareness of interactions—especially with medicines that bind bile acids.

Always follow the instructions on your pack and speak to a healthcare professional or pharmacist for personalised advice.